| Financial Year |
March 31 2023 |
| Monetary Funds |
2,709,772,586.98 |
| Held-for-trading Financial Assets |
123,394,890.68 |
| Notes Receivable |
-- |
| Accounts Receivable |
554,151,193.69 |
| Advances to Suppliers |
17,035,518.25 |
| Other Receivables |
906,683,478.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
1,453,744.81 |
| Inventories |
3,834,679,222.12 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
386,490,398.28 |
| Total Current Assets |
8,532,207,288.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
5,560,567,732.09 |
| Investment Properties |
13,666,055,222.42 |
| Fixed Assetes |
97,593,634.11 |
| Under-construction Projects |
232,324,846.55 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
7,671,877.05 |
| R&D expenses |
-- |
| Goodwill |
1,263,692,231.81 |
| Long-Term Deferred and Prepaid Expenses |
37,047,033.95 |
| Deferred Income Tax Assets |
290,055,064.91 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
21,482,381,925.43 |
| Total Assets |
30,014,589,213.92 |
| Short-Term Loans |
396,358,669.36 |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,245,826.52 |
| Accounts Payable |
910,719,961.47 |
| Accounts Received In Advance |
106,272,366.46 |
| Employee Compensation Payable |
184,326,868.55 |
| Taxes Payable |
455,300,275.25 |
| Interest Payable |
-- |
| Dividend Payable |
16,339,593.11 |
| Other payables |
3,424,491,863.96 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
405,354,103.42 |
| Other Current Liabilities |
188,520,006.63 |
| Sub-Total of Current Liabilities |
8,365,576,659.02 |
| Long-term Loans |
7,917,063,522.86 |
| Bonds Payable |
2,709,616,269.76 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
20,196,886.00 |
| Deferred Income Tax Liabilities |
1,255,074,895.59 |
| Other Non-Current Liabilities |
651,129,701.36 |
| Sub-Total of Non-Current Liabilities |
12,609,667,377.80 |
| Total Liabilities |
20,975,244,036.82 |
| Paid-In Capital(Or Share Stock) |
1,499,685,402.00 |
| Capital Surplus |
1,414,184,882.24 |
| Surplus Reserve |
305,570,286.20 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,793,113,247.65 |
| Minority Stockholder's Interest |
1,989,567,799.99 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,049,777,377.11 |
| Owner's Equity（Stockholder's Equity） |
9,039,345,177.10 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
30,014,589,213.92 |
